Cargando…
High levels of anxiety during the COVID-19 pandemic as a risk factor of clinical worsening in patients with severe asthma
Autores principales: | Lacwik, Piotr, Szydłowska, Dorota, Kupczyk, Maciej, Pałczyński, Cezary, Kuna, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797186/ https://www.ncbi.nlm.nih.gov/pubmed/33440258 http://dx.doi.org/10.1016/j.jaip.2020.12.060 |
Ejemplares similares
-
Prevalence, risk factors and underdiagnosis of asthma in the general population aged over 60 years
por: Kuprys-Lipinska, Izabela, et al.
Publicado: (2019) -
Omalizumab therapy in a patient with severe asthma and co-existing chronic obstructive pulmonary disease
por: Kupryś-Lipińska, Izabela, et al.
Publicado: (2018) -
Cross-cultural adaptation and validation of the RhinAsthma Patient Perspective (RAPP) in the Polish population
por: Kupczyk, Maciej, et al.
Publicado: (2020) -
Clinical profiles of patients referred for biological therapy and major limitations in the qualification paths in a specialist asthma centre
por: Damiański, Piotr, et al.
Publicado: (2023) -
Inhaled Corticosteroids in Asthma: Promoting or Protecting Against Atherosclerosis?
por: Podgórski, Michał, et al.
Publicado: (2017)